COMP <GO>
ZWS vs TMO // ENTERPRISE SCALE & MARKET CAP
Zurn Elkay Water Solutions Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ZWS 10
— TMO 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $44.80 (+0.16%) • MKT CAP: $7.38B
market-cap
$7.38B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZWS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZWS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.10% | 41.00% | +4.10 | ZWS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.30% | 9.30% | +3.00 | ZWS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.0x | 30.4x | -8.40 | ZWS | /valuation <GO> |
| Free Cash Flow Yield | 3.66% | 2.40% | +1.26 | ZWS | /fcf-yield <GO> |
| Operating Margin | 16.40% | 17.40% | -1.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 11.70% | 15.10% | -3.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 3.90% | +4.40 | ZWS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.87% | 0.24% | +0.63 | ZWS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.75 | 4.50 | +0.25 | ZWS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | ZWS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.4 | 59.1 | -20.80 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.94 | +0.04 | ZWS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.7x | 36.3x | -1.60 | ZWS | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $7.38B | $262.22B | -$254.83B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZWS REV | TMO REV | ZWS GROSS % | TMO GROSS % | ZWS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.70B | $44.56B | 45.1% | 44.0% | $270.2M | $6.29B |
| FY 2024 | $1.57B | $42.88B | 45.1% | 44.0% | $223.0M | $7.27B |
| FY 2023 | $1.53B | $42.86B | 44.0% | 44.0% | $185.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZWS // BETA 0.98
TMO // BETA 0.94